OBG3 globular head and uses thereof

   
   

The present invention relates to the field of obesity research. Obesity is a public health problem that is serious and widespread. A compound, globular OBG3, has been identified that reduces weight gain in animals. This compound should be effective for reducing body mass and for treating obesity-related diseases and disorders. These obesity-related diseases and disorders include hyperlipidemias, atherosclerosis, diabetes, and hypertension.

A invenção atual relaciona-se ao campo da pesquisa do obesity. O obesity é um problema de saúde pública que seja sério e difundido. Um composto, OBG3 globular, foi identificado que reduz o ganho do peso nos animais. Este composto deve ser eficaz para reduzir a massa do corpo e para doenças e disorders obesity-relacionados de tratamento. Estes doenças e disorders obesity-relacionados incluem hyperlipidemias, atherosclerosis, diabetes, e hypertension.

 
Web www.patentalert.com

< Modulation of beta-catenin/TCF-activated transcription

< Heterocyclic ketone and thioester compounds and uses

> Modulators of ATP-binding cassette transporters

> Per-6-substituted-per-6-deoxy-cyclodextrins, and use of the same to inhibit soluble beta-amyloid-peptide derived oligomers and to treat alzheimer's and related diseases

~ 00168